Cerebrolysin Peptide is a porcine-brain-derived peptide complex containing biologically active neuropeptides and free amino acids. This research-grade lyophilized concentrate is produced under strict GMP conditions and provided with full analytical documentation. For Research Use Only. Not for human use.
Key Scientific Attributes
- High-purity Cerebrolysin peptide fraction (15% peptides <10 kDa, 85% free amino acids)
- Lyophilized concentrate (215.2 mg solids per vial)
- Full Certificate of Analysis (COA) with HPLC, amino acid profile, molecular weight distribution, and in-vitro neuroprotection assay
- Manufactured in GMP-aligned, ISO-compliant facilities
- Suitable for neurological and neuroregeneration research applications
Research-Referenced Attributes (Based on preclinical literature; not therapeutic claims.)
- Research into neurotrophic factor modulation, including BDNF and NGF pathways, in ischemic brain tissue models
- Investigated for effects on amyloid-β and tau phosphorylation in preclinical research models
- Studied in preclinical models of brain and spinal cord injury
- Subject of ongoing scientific investigation into neuroprotective mechanisms (onlinelibrary.wiley.com)
Why Researchers Choose Cerebrolysin Peptide
- Pharmaceutical-grade composition suitable for use in clinical and preclinical research studies
- Transparent analytical data (peptide MW profile + in-vitro neuroprotection assay)
- Competitive research pricing with bulk options
For Research Use Only. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any condition.
